<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">282</journal-id><journal-id journal-id-type="pmc-domain">brjpharm</journal-id><journal-title-group><journal-title>British Journal of Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0007-1188</issn><issn pub-type="epub">1476-5381</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC1572173</article-id><article-id pub-id-type="pmcid-ver">PMC1572173.1</article-id><article-id pub-id-type="pmcaid">1572173</article-id><article-id pub-id-type="pmcaiid">1572173</article-id><article-id pub-id-type="pmid">10882388</article-id><article-id pub-id-type="doi">10.1038/sj.bjp.0703417</article-id><article-id pub-id-type="pii">0703417</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Papers</subject></subj-group></article-categories><title-group><article-title>Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects <italic>versus</italic> brain GABA levels</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cleton</surname><given-names initials="A">A</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Altorf</surname><given-names initials="BA">B A</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Voskuyl</surname><given-names initials="RA">R A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Danhof</surname><given-names initials="M">M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label><sup>1</sup>Division of Pharmacology, Leiden Amsterdam Center for Drug Research, Leiden University, P.O. Box 9503, 2300 RA Leiden, The Netherlands</aff><aff id="aff2"><label>2</label><sup>2</sup>Stichting Epilepsie Instellingen Nederland, Achterweg 5, 2103 SW Heemstede, The Netherlands</aff><aff id="aff3"><label>3</label><sup>3</sup>Department of Physiology, Leiden University Medical Center, P.O. Box 9604, 2300 RC Leiden, The Netherlands</aff><author-notes><corresp id="caf1"><label>*</label>Author for correspondence: </corresp></author-notes><pub-date pub-type="ppub"><month>07</month><year>2000</year></pub-date><volume>130</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">134840</issue-id><fpage>1037</fpage><lpage>1044</lpage><history><date date-type="received"><day>15</day><month>10</month><year>1999</year></date><date date-type="rev-recd"><day>01</day><month>03</month><year>2000</year></date><date date-type="accepted"><day>07</day><month>04</month><year>2000</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2001</year></date></event><event event-type="pmc-live"><date><day>10</day><month>01</month><year>2008</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2010-12-23 17:18:08.693"><day>23</day><month>12</month><year>2010</year></date></event></pub-history><permissions><copyright-statement>Copyright 2000, Nature Publishing Group</copyright-statement><copyright-year>2000</copyright-year><copyright-holder>Nature Publishing Group</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="130-0703417a.pdf"/><abstract><p><list list-type="order"><list-item><p>The objective of this investigation was to determine the influence of amygdala kindling on the pharmacodynamics of tiagabine <italic>in vivo</italic>, using quantitative EEG parameters and extracellular GABA concentrations as pharmacodynamic endpoints. In integrated pharmacokinetic/pharmacodynamic (PK/PD) studies the time course of these effects was determined in conjunction with plasma concentrations following intravenous administration of 10&#8201;mg&#8201;kg<sup>&#8722;1</sup>. An &#8216;effect compartment' model was used to derive individual concentration&#8211;effect relationships.</p></list-item><list-item><p>Tiagabine produced an increase in the amplitude of the 11.5&#8211;30&#8201;Hz frequency band of the EEG. The relationship between concentration and EEG effect was non-linear and described by the Hill equation. In kindled rats the EC<sub>50</sub> was reduced to 291&#8201;ng&#8201;ml<sup>&#8722;1</sup> from the original value of 521&#8201;ng&#8201;ml<sup>&#8722;1</sup> in controls. The values of all other parameters were unchanged.</p></list-item><list-item><p>In kindled rats the baseline extracellular GABA concentration was increased to 1.58&#8201;&#956;<sc>M</sc> from 0.74&#8201;&#956;<sc>M</sc> in controls. The relationships between tiagabine concentration and extracellular GABA concentration were again non-linear and described by the Hill equation. No differences were observed between kindled rats and controls. In the synaptoneurosmal preparation <italic>in vitro</italic> no changes in the functioning of the GABA transporter were observed.</p></list-item><list-item><p>It is concluded that unlike the situation with midazolam, there is no resistance to the EEG effect of tiagabine in the kindling model of experimental epilepsy. The observed shift in the concentration&#8211;EEG effect relationship to lower concentrations can presumably be explained by the increase in the baseline GABA levels.</p></list-item></list></p></abstract><kwd-group><kwd>Pharmacokinetics</kwd><kwd>pharmacodynamics</kwd><kwd>amygdala kindling</kwd><kwd>tiagabine</kwd><kwd>GABA uptake inhibitor</kwd><kwd>GABA uptake transporter</kwd><kwd>microdialysis</kwd><kwd>brain GABA concentration</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>